In vitro immune organs-on-chip for drug development

A review

Aya Shanti, Jeremy Teo, Cesare Stefanini

Research output: Contribution to journalReview article

Abstract

The current drug development practice lacks reliable and sensitive techniques to evaluate the immunotoxicity of drug candidates, i.e., their effect on the human immune system. This, in part, has resulted in a high attrition rate for novel drugs candidates. Organ-on-chip devices have emerged as key tools that permit the study of human physiology in controlled in vivo simulating environments. Furthermore, there has been a growing interest in developing the so called “body-on-chip” devices to better predict the systemic effects of drug candidates. This review describes existing biomimetic immune organs-on-chip, highlights their physiological relevance to drug development and discovery and emphasizes the need for developing comprehensive immune system-on-chip models. Such immune models can enhance the performance of novel drug candidates during clinical trials and contribute to reducing the high attrition rate as well as the high cost associated with drug development.

Original languageEnglish (US)
Article number278
JournalPharmaceutics
Volume10
Issue number4
DOIs
StatePublished - Dec 1 2018

Fingerprint

Pharmaceutical Preparations
Immune System
Equipment and Supplies
Biomimetics
Drug Discovery
In Vitro Techniques
Clinical Trials
Costs and Cost Analysis

Keywords

  • Biomimicry
  • Drug development
  • Drug discovery
  • Immune system
  • In vitro
  • Organ-on-chip

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

In vitro immune organs-on-chip for drug development : A review. / Shanti, Aya; Teo, Jeremy; Stefanini, Cesare.

In: Pharmaceutics, Vol. 10, No. 4, 278, 01.12.2018.

Research output: Contribution to journalReview article

Shanti, Aya ; Teo, Jeremy ; Stefanini, Cesare. / In vitro immune organs-on-chip for drug development : A review. In: Pharmaceutics. 2018 ; Vol. 10, No. 4.
@article{26d32fd3dedf4d6783737de13775f01e,
title = "In vitro immune organs-on-chip for drug development: A review",
abstract = "The current drug development practice lacks reliable and sensitive techniques to evaluate the immunotoxicity of drug candidates, i.e., their effect on the human immune system. This, in part, has resulted in a high attrition rate for novel drugs candidates. Organ-on-chip devices have emerged as key tools that permit the study of human physiology in controlled in vivo simulating environments. Furthermore, there has been a growing interest in developing the so called “body-on-chip” devices to better predict the systemic effects of drug candidates. This review describes existing biomimetic immune organs-on-chip, highlights their physiological relevance to drug development and discovery and emphasizes the need for developing comprehensive immune system-on-chip models. Such immune models can enhance the performance of novel drug candidates during clinical trials and contribute to reducing the high attrition rate as well as the high cost associated with drug development.",
keywords = "Biomimicry, Drug development, Drug discovery, Immune system, In vitro, Organ-on-chip",
author = "Aya Shanti and Jeremy Teo and Cesare Stefanini",
year = "2018",
month = "12",
day = "1",
doi = "10.3390/pharmaceutics10040278",
language = "English (US)",
volume = "10",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

TY - JOUR

T1 - In vitro immune organs-on-chip for drug development

T2 - A review

AU - Shanti, Aya

AU - Teo, Jeremy

AU - Stefanini, Cesare

PY - 2018/12/1

Y1 - 2018/12/1

N2 - The current drug development practice lacks reliable and sensitive techniques to evaluate the immunotoxicity of drug candidates, i.e., their effect on the human immune system. This, in part, has resulted in a high attrition rate for novel drugs candidates. Organ-on-chip devices have emerged as key tools that permit the study of human physiology in controlled in vivo simulating environments. Furthermore, there has been a growing interest in developing the so called “body-on-chip” devices to better predict the systemic effects of drug candidates. This review describes existing biomimetic immune organs-on-chip, highlights their physiological relevance to drug development and discovery and emphasizes the need for developing comprehensive immune system-on-chip models. Such immune models can enhance the performance of novel drug candidates during clinical trials and contribute to reducing the high attrition rate as well as the high cost associated with drug development.

AB - The current drug development practice lacks reliable and sensitive techniques to evaluate the immunotoxicity of drug candidates, i.e., their effect on the human immune system. This, in part, has resulted in a high attrition rate for novel drugs candidates. Organ-on-chip devices have emerged as key tools that permit the study of human physiology in controlled in vivo simulating environments. Furthermore, there has been a growing interest in developing the so called “body-on-chip” devices to better predict the systemic effects of drug candidates. This review describes existing biomimetic immune organs-on-chip, highlights their physiological relevance to drug development and discovery and emphasizes the need for developing comprehensive immune system-on-chip models. Such immune models can enhance the performance of novel drug candidates during clinical trials and contribute to reducing the high attrition rate as well as the high cost associated with drug development.

KW - Biomimicry

KW - Drug development

KW - Drug discovery

KW - Immune system

KW - In vitro

KW - Organ-on-chip

UR - http://www.scopus.com/inward/record.url?scp=85059343815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059343815&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics10040278

DO - 10.3390/pharmaceutics10040278

M3 - Review article

VL - 10

JO - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 4

M1 - 278

ER -